Mona Arianejad

Combination of CIK cells with oncolytic viruses: A potential Immunovirotherapy strategy for the treatment of solid tumors

Cytokine-induced killer (CIK) cells represent a promising cellular immunotherapy, characterized by potent cytotoxicity, major histocompatibility complex (MHC)-unrestricted tumor recognition, and ease of ex vivo expansion. Despite these properties, their clinical efficacy against...